Semavik is the Russian analogue of Ozempic.

Today, about 2.6 billion people are overweight or obese, representing approximately 38% of the world's population. Ozempic was developed to help people control their blood it has been proven to help people lose weight. Not all people with type 2 diabetes are obese, but the two diseases are closely related. How do Ozempic and Semavik work?